FDA MoCRA: Cosmetic Compliance & Registration
Before the Modernization of Cosmetics Regulation Act (MoCRA) was signed into law in December 2022, cosmetic manufacturers could legally sell products in the US without ever registering with the FDA or listing a single product ingredient. The FDA had no authority to recall unsafe cosmetics, no mandatory adverse event reporting system for cosmetics, and no requirement that manufacturers substantiate product safety. MoCRA changed all of that in a single legislative package — the most significant overhaul of US cosmetic regulation since the Federal Food, Drug, and Cosmetic Act of 1938.
MoCRA imposes mandatory facility registration, product listing, safety substantiation, adverse event reporting, and — for the first time — gives the FDA mandatory recall authority over cosmetics. On the Sustalium platform, the MoCRA-related compliance activity we see most is cosmetic brands and contract manufacturers reconciling their ingredient lists with the FDA's product listing format — because the FDA's electronic submission portal requires structured ingredient data, and most brands' internal records are not yet structured to match.